Iis Inayati Rakhmat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Iis Inayati Rakhmat has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Dewi Ratih Handayani
Doctorate Program, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia. Department of Biochemistry, Faculty of Medicine, Universitas Jenderal Achmad Yani, Cimahi, Indonesia
3 shared publications - Eka Noneng Nawangsih
Department of Microbiology Faculty of Medicine Universitas Jenderal Achmad Yani Cimahi Indonesia
3 shared publications - Raymond Pranata
Faculty of Medicine Universitas Pelita Harapan Tangerang Indonesia
3 shared publications - Yudith Yunia Kusmala
Department of Internal Medicine, Faculty of Medicine, Universitas Jenderal Achmad Yani, Cimahi, Indonesia
3 shared publications Arief Wibowo
Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Padjadjaran, Rumah Sakit Umum Pusat Hasan Sadikin, Bandung, Indonesia
2 shared publications- Eko Fuji Ariyanto
Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Sumedang, Indonesia
2 shared publications
Latest Publications
- Open Access
- 21 January 2026
- Published by Wiley in Obesity Science & Practice
- Vol. 12 (1)
Recent Insights Into Circulating Adipokines in Obesity: Systematic Review and Meta‐Analysis
Background: Adipokines are dysregulated in obesity and exacerbate proinflammatory conditions. Although several studies have investigated adipokine levels in obesity, their findings have been inconsistent, leaving the precise nature of these alterations uncertain. This systematic review and meta‐analysis aimed to provide an updated overview of circulating adipokines, particularly adiponectin, leptin, fibroblast growth factor 21 (FGF21), growth differentiation factor 15 (GDF15), interleukin‐6 (IL‐6), and tumor necrosis factor‐α (TNF‐α) in the context of obesity. Methods: This study adhered to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines and PROSPERO registration (CRD42024525103). PubMed/MEDLINE, Scopus, and Journal of Clinical Investigation databases were searched from inception to August 25, 2025. Eligible observational studies were assessed using the ROBINS‐I and GRADE frameworks. Standardized mean differences (SMDs) were calculated using a random‐effects model. Results: From 2378 records, 30 and 16 studies were included in the review and meta‐analysis, respectively. Adiponectin levels were significantly lower in persons with obesity than in those with normal weight ( p = 0.007). Conversely, leptin, TNF‐α, and FGF21 levels were significantly higher in persons with obesity ( p < 0.01). No significant differences were found for GDF15 ( p = 0.62) and IL‐6 ( p = 0.17). Conclusions: Adiponectin, leptin, TNF‐α, and FGF21 show consistent directionality and may serve as robust biomarkers in obesity‐related risk profiling. Conversely, GDF15 and IL‐6 exhibit context‐dependent variability. Further prospective cohort studies are warranted to better understand these adipokines, as persons with normal weight may still be at a high risk of cardiometabolic diseases.
- 21 January 2026
- Published by Wiley in Obesity Science & Practice
- Vol. 12 (1)
Open AccessRecent Insights Into Circulating Adipokines in Obesity: Systematic Review and Meta‐Analysis
Background: Adipokines are dysregulated in obesity and exacerbate proinflammatory conditions. Although several studies have investigated adipokine levels in obesity, their findings have been inconsistent, leaving the precise nature of these alterations uncertain. This systematic review and meta‐analysis aimed to provide an updated overview of circulating adipokines, particularly adiponectin, leptin, fibroblast growth factor 21 (FGF21), growth differentiation factor 15 (GDF15), interleukin‐6 (IL‐6), and tumor necrosis factor‐α (TNF‐α) in the context of obesity. Methods: This study adhered to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines and PROSPERO registration (CRD42024525103). PubMed/MEDLINE, Scopus, and Journal of Clinical Investigation databases were searched from inception to August 25, 2025. Eligible observational studies were assessed using the ROBINS‐I and GRADE frameworks. Standardized mean differences (SMDs) were calculated using a random‐effects model. Results: From 2378 records, 30 and 16 studies were included in the review and meta‐analysis, respectively. Adiponectin levels were significantly lower in persons with obesity than in those with normal weight ( p = 0.007). Conversely, leptin, TNF‐α, and FGF21 levels were significantly higher in persons with obesity ( p < 0.01). No significant differences were found for GDF15 ( p = 0.62) and IL‐6 ( p = 0.17). Conclusions: Adiponectin, leptin, TNF‐α, and FGF21 show consistent directionality and may serve as robust biomarkers in obesity‐related risk profiling. Conversely, GDF15 and IL‐6 exhibit context‐dependent variability. Further prospective cohort studies are warranted to better understand these adipokines, as persons with normal weight may still be at a high risk of cardiometabolic diseases.
- Open Access
- 30 December 2025
- Published by MEDIKA KARTIKA : JURNAL KEDOKTERAN DAN KESEHATAN in Medika Kartika : Jurnal Kedokteran dan Kesehatan
- Vol. 8 (Volume 8 N) , 423-433
DIFFERENCES IN HDL AND TRIGLYCERIDE LEVELS IN OBESE AND NOR-MAL-WEIGHT PATIENTS WITH METABOLIC SYNDROME: A LITERATURE REVIEW
Metabolic Syndrome (MS) is a cluster of complex metabolic disorders characterized by central obesity, insulin resistance, dyslipidemia, and hypertension, which collectively increase the risk of cardiovascular disease. One important indicator of dyslipidemia is the triglyceride-to-high-density lipoprotein (HDL) ratio, where elevated triglycerides and reduced HDL levels reflect an imbalance in lipid metabolism. The risk of MS is not only found in obese individuals but also in those with normal body weight (metabolically obese normal-weight individuals), indi-cating that visceral fat distribution, genetic factors, and lifestyle also play a role. This literature review aims to examine differences in HDL and triglyceride levels in MS patients with obesity and normal body weight. Articles were searched through PubMed, DOAJ, Google Scholar, and GARUDA databases within the last 10 years using relevant keywords. Of the 18 articles that met the inclusion criteria, the review showed a consistent pattern indicating that individu-als with MS, whether in the obese or normal-weight groups, exhibited elevated triglyceride levels accompanied by significantly reduced HDL levels. These findings highlight that lipid abnormalities represent a central mechanism in MS that contributes to the risk of atherosclero-sis and cardiovascular disease, regardless of body weight status. In conclusion, this review demonstrates that there are differences in triglyceride and HDL levels among MS patients with obesity and those with normal body weight, suggesting that lipid profile evaluation should be a primary focus in cardiometabolic disease prevention strategies. Keywords: dyslipidemia, high-density lipoprotein (HDL), obesity, metabolic syndrome, tri-glycerides
- 30 December 2025
- Published by MEDIKA KARTIKA : JURNAL KEDOKTERAN DAN KESEHATAN in Medika Kartika : Jurnal Kedokteran dan Kesehatan
- Vol. 8 (Volume 8 N) , 423-433
Open AccessDIFFERENCES IN HDL AND TRIGLYCERIDE LEVELS IN OBESE AND NOR-MAL-WEIGHT PATIENTS WITH METABOLIC SYNDROME: A LITERATURE REVIEW
Metabolic Syndrome (MS) is a cluster of complex metabolic disorders characterized by central obesity, insulin resistance, dyslipidemia, and hypertension, which collectively increase the risk of cardiovascular disease. One important indicator of dyslipidemia is the triglyceride-to-high-density lipoprotein (HDL) ratio, where elevated triglycerides and reduced HDL levels reflect an imbalance in lipid metabolism. The risk of MS is not only found in obese individuals but also in those with normal body weight (metabolically obese normal-weight individuals), indi-cating that visceral fat distribution, genetic factors, and lifestyle also play a role. This literature review aims to examine differences in HDL and triglyceride levels in MS patients with obesity and normal body weight. Articles were searched through PubMed, DOAJ, Google Scholar, and GARUDA databases within the last 10 years using relevant keywords. Of the 18 articles that met the inclusion criteria, the review showed a consistent pattern indicating that individu-als with MS, whether in the obese or normal-weight groups, exhibited elevated triglyceride levels accompanied by significantly reduced HDL levels. These findings highlight that lipid abnormalities represent a central mechanism in MS that contributes to the risk of atherosclero-sis and cardiovascular disease, regardless of body weight status. In conclusion, this review demonstrates that there are differences in triglyceride and HDL levels among MS patients with obesity and those with normal body weight, suggesting that lipid profile evaluation should be a primary focus in cardiometabolic disease prevention strategies. Keywords: dyslipidemia, high-density lipoprotein (HDL), obesity, metabolic syndrome, tri-glycerides
- Open Access
- 1 February 2024
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 17, 833-839
Strong Association of Metabolic Parameters with ADMA and VCAM-1 in Normo-Weight Subjects with Metabolic Syndrome
Background: Metabolic syndrome (MetS) is a risk factor for cardiovascular disease and is linked to obesity. Subjects with MetS who have normo-weight potentially show higher mortality and morbidity. Purpose: This study aims to reveal the critical essential metabolic parameters associated with endothelial dysfunction in MetS subjects with normo-weight compared to obese. Patients and Methods: The study was designed using a case–control approach. Ninety-nine MetS subjects (34 Normo-weight and 65 obese) from the urban population were enrolled in this study. The components of MetS are based on NCEP/ATP III criteria. Asymmetric dimethylarginine (ADMA) and vascular cell adhesion molecule 1 (VCAM-1) as markers for endothelial dysfunction were measured in both groups. Results: Fasting blood glucose (FBG) levels were higher in the normo-weight group (143.38 ± 79.8 mg/dL) compared to the obese group (120.89 ± 46.5 mg/dL). High-density lipoprotein cholesterol (HDL-c) levels in the normo-weight group were lower (42.82 ± 10.1 mg/dL) compared to obesity (45.74 ± 9.3 mg/dL), while triacylglycerol (TAG) levels were higher in the obese (197.25 ± 110.5 mg/dL) compared to the normo-weight group (167.03 ± 98.4 mg/dL), although the differences were statistically not significant (all p > 0.05). The difference between ADMA and VCAM-1 levels was statistically not significant in both groups. Correlation between MetS components with endothelial dysfunction parameters shows that metabolic parameters correlate strongly. Interestingly, a stronger correlation between FBG and ADMA was observed in normo-weight (r = 0.519) compared to obese groups (r = 0.445). In addition, TAG consistently shows a significant correlation with ADMA and VCAM-1 in normo-weight groups. Conclusion: Metabolic parameters, especially FBG and TAG, correlate strongly with endothelial dysfunction parameters in normo-weight subjects with metabolic syndrome.
- 1 February 2024
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 17, 833-839
Open AccessStrong Association of Metabolic Parameters with ADMA and VCAM-1 in Normo-Weight Subjects with Metabolic Syndrome
Background: Metabolic syndrome (MetS) is a risk factor for cardiovascular disease and is linked to obesity. Subjects with MetS who have normo-weight potentially show higher mortality and morbidity. Purpose: This study aims to reveal the critical essential metabolic parameters associated with endothelial dysfunction in MetS subjects with normo-weight compared to obese. Patients and Methods: The study was designed using a case–control approach. Ninety-nine MetS subjects (34 Normo-weight and 65 obese) from the urban population were enrolled in this study. The components of MetS are based on NCEP/ATP III criteria. Asymmetric dimethylarginine (ADMA) and vascular cell adhesion molecule 1 (VCAM-1) as markers for endothelial dysfunction were measured in both groups. Results: Fasting blood glucose (FBG) levels were higher in the normo-weight group (143.38 ± 79.8 mg/dL) compared to the obese group (120.89 ± 46.5 mg/dL). High-density lipoprotein cholesterol (HDL-c) levels in the normo-weight group were lower (42.82 ± 10.1 mg/dL) compared to obesity (45.74 ± 9.3 mg/dL), while triacylglycerol (TAG) levels were higher in the obese (197.25 ± 110.5 mg/dL) compared to the normo-weight group (167.03 ± 98.4 mg/dL), although the differences were statistically not significant (all p > 0.05). The difference between ADMA and VCAM-1 levels was statistically not significant in both groups. Correlation between MetS components with endothelial dysfunction parameters shows that metabolic parameters correlate strongly. Interestingly, a stronger correlation between FBG and ADMA was observed in normo-weight (r = 0.519) compared to obese groups (r = 0.445). In addition, TAG consistently shows a significant correlation with ADMA and VCAM-1 in normo-weight groups. Conclusion: Metabolic parameters, especially FBG and TAG, correlate strongly with endothelial dysfunction parameters in normo-weight subjects with metabolic syndrome.
- Open Access
- 16 December 2022
- Published by Atlantis Press SARL
- p. 84-94
The Effect of Rambutan Honey and Rutin on Decrease Blood Glucose and Increase Streptozotocin-Induced Rat Plasma Insulin
- 16 December 2022
- Published by Atlantis Press SARL
- p. 84-94
Open AccessThe Effect of Rambutan Honey and Rutin on Decrease Blood Glucose and Increase Streptozotocin-Induced Rat Plasma Insulin
- Open Access
- 24 July 2021
- Published by Atlantis Press SARL
- p. 64-66
Flavonoid-Rutin Effect to Blood Glucose Level and Pancreas Regeneration in Diabetic Rats
- 24 July 2021
- Published by Atlantis Press SARL
- p. 64-66
Open AccessFlavonoid-Rutin Effect to Blood Glucose Level and Pancreas Regeneration in Diabetic Rats
- Open Access
- 24 July 2021
- Published by Atlantis Press SARL
- p. 24-28
The Comparison of Ethanol Extract Breadfruit Leaf and Glibenclamide Towards the Decreasing of Blood Glucose Levels in Rats with Diabetes Mellitus Induced by Alloxan
- 24 July 2021
- Published by Atlantis Press SARL
- p. 24-28
Open AccessThe Comparison of Ethanol Extract Breadfruit Leaf and Glibenclamide Towards the Decreasing of Blood Glucose Levels in Rats with Diabetes Mellitus Induced by Alloxan
- 1 May 2021
- Published by Elsevier in Obesity Medicine
- Vol. 23, 100333
Prognostic value of fasting hyperglycemia in patients with COVID-19 – Diagnostic test accuracy meta-analysis
- 1 May 2021
- Published by Elsevier in Obesity Medicine
- Vol. 23, 100333
Prognostic value of fasting hyperglycemia in patients with COVID-19 – Diagnostic test accuracy meta-analysis
- 27 April 2021
- Published by Elsevier in International Immunopharmacology
- Vol. 96, 107723
Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression
- 27 April 2021
- Published by Elsevier in International Immunopharmacology
- Vol. 96, 107723
Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression
- Open Access
- 28 November 2019
- Published by Atma Jaya Catholic University of Indonesia in MITRA: Jurnal Pemberdayaan Masyarakat
- Vol. 3 (2) , 151-163
Secercah Hati: Community Empowerment Program in Health and Economic Affairs through the Role of Posyandu and Posbindu
The poverty level of urban communities, indicated by the high rate of maternal and infant mortality, the presence of stunting problems, and the poor health of the elderly in the Cibereum Village, Cimahi City, have an impact on the lack of concern for individual health and environmental health. The Secercah Hati program is created with the purpose of overcoming such problems. This program is a community empowerment program to create a healthy, knowledgeable, and prosperous society by increasing the role of women. It is collaborating with the Cimahi City Government Program, based on the 2017-2022 Cimahi City Medium Term Development Plan (RPJMD). Furthermore, the Secercah Hati Program is also an implementation of a partnership which is not only between Jenderal Achmad Yani University and the Cimahi City Government but also with Pasundan University. The program attempts to solve the issues by improving the role of Posyandu and Posbindu. The method of activity begins with a situation analysis that is coordinated with Cimahi City Government, problem identification, gathering and analyzing needs, determining priority problems, providing solutions, implementing, and evaluating. This participatory empowerment activity was carried out by forming a women's community consisting of Posyandu and Posbindu managers. Empowerment was implemented through training, workshops, mentoring, and role play (theatrical), so that they could optimize their role in improving public health and the environment and supporting the family economy. They were taught the ability to produce culinary with strong branding and market products utilizing digital marketing. In addition, they learnt to manage capital to support business sustainability. The program has an impact on increasing the number of cadres and the level of community participation in Posyandu and Posbindu activities, increasing the number of women entrepreneurs and increasing community income. The success of this community empowerment program needs to be supported by the concept of exciting and measurable activities in order to get a positive response from the community. Mentoring activities would be conducted continuously until the community is accustomed to and able to run programs independently and this is one of the keys to success. Implementing activities that synergize the Regional Government, Universities, and the community have proven to make the community empowerment program more effective.
- 28 November 2019
- Published by Atma Jaya Catholic University of Indonesia in MITRA: Jurnal Pemberdayaan Masyarakat
- Vol. 3 (2) , 151-163
Open AccessSecercah Hati: Community Empowerment Program in Health and Economic Affairs through the Role of Posyandu and Posbindu
The poverty level of urban communities, indicated by the high rate of maternal and infant mortality, the presence of stunting problems, and the poor health of the elderly in the Cibereum Village, Cimahi City, have an impact on the lack of concern for individual health and environmental health. The Secercah Hati program is created with the purpose of overcoming such problems. This program is a community empowerment program to create a healthy, knowledgeable, and prosperous society by increasing the role of women. It is collaborating with the Cimahi City Government Program, based on the 2017-2022 Cimahi City Medium Term Development Plan (RPJMD). Furthermore, the Secercah Hati Program is also an implementation of a partnership which is not only between Jenderal Achmad Yani University and the Cimahi City Government but also with Pasundan University. The program attempts to solve the issues by improving the role of Posyandu and Posbindu. The method of activity begins with a situation analysis that is coordinated with Cimahi City Government, problem identification, gathering and analyzing needs, determining priority problems, providing solutions, implementing, and evaluating. This participatory empowerment activity was carried out by forming a women's community consisting of Posyandu and Posbindu managers. Empowerment was implemented through training, workshops, mentoring, and role play (theatrical), so that they could optimize their role in improving public health and the environment and supporting the family economy. They were taught the ability to produce culinary with strong branding and market products utilizing digital marketing. In addition, they learnt to manage capital to support business sustainability. The program has an impact on increasing the number of cadres and the level of community participation in Posyandu and Posbindu activities, increasing the number of women entrepreneurs and increasing community income. The success of this community empowerment program needs to be supported by the concept of exciting and measurable activities in order to get a positive response from the community. Mentoring activities would be conducted continuously until the community is accustomed to and able to run programs independently and this is one of the keys to success. Implementing activities that synergize the Regional Government, Universities, and the community have proven to make the community empowerment program more effective.